Pharmacy Closures and Anticonvulsant Medication Prescription Fills
While the number of US community pharmacies has remained somewhat constant, there is significant instability with 1 in 8 community pharmacies closing from 2009 to 2015.1 The effects of pharmacy closures on medication use are not well understood. Anticonvulsants are a protected class of Medicare drug...
Gespeichert in:
Veröffentlicht in: | JAMA : the journal of the American Medical Association 2024-12, Vol.332 (21), p.1847-1849 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1849 |
---|---|
container_issue | 21 |
container_start_page | 1847 |
container_title | JAMA : the journal of the American Medical Association |
container_volume | 332 |
creator | Anderson, Kelly E Sahu, Maitreyi DiStefano, Michael J Asche, Carl V Mattingly, T. Joseph |
description | While the number of US community pharmacies has remained somewhat constant, there is significant instability with 1 in 8 community pharmacies closing from 2009 to 2015.1 The effects of pharmacy closures on medication use are not well understood. Anticonvulsants are a protected class of Medicare drugs; plans must include them on formularies and have limitations on utilization management. Anticonvulsants are primarily indicated to treat epilepsy but are also used for neuropathic pain, migraine prophylaxis, and psychiatric disorders. Nonadherence has been linked to increased mortality and emergency department visits for epilepsy, and patients with untreated or undertreated neuropathic pain may experience worsening symptoms.2,3 This study examined the relationship between pharmacy closures and anticonvulsant prescription fills and number of days supplied in Colorado. |
doi_str_mv | 10.1001/jama.2024.19993 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3123807160</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>2825803</ama_id><sourcerecordid>3145214769</sourcerecordid><originalsourceid>FETCH-LOGICAL-a188t-64cecd464eb36da3248f5c75c41f4c0b96e1f7303c0626c8f2712c5e1bdfffcb3</originalsourceid><addsrcrecordid>eNpd0E1LAzEQBuAgiq3Vs-BBFrx42TXJ5PNYi1WhYg96XrLZBLfsR93sCv33Bls9OJdhmIdheBG6JDgjGJO7jWlMRjFlGdFawxGaEg4qBa7VMZpirFUqmWITdBbCBsciIE_RBDTTnIOcovv1h-kbY3fJou7C2LuQmLZM5u1Q2a79Gutg2iF5cWVlzVB1bbKOxPbV9mdYVnUdztGJN3VwF4c-Q-_Lh7fFU7p6fXxezFepIUoNqWDW2ZIJ5goQpQHKlOdWcsuIZxYXWjjiJWCwWFBhlaeSUMsdKUrvvS1ghm73d7d99zm6MORNFayra9O6bgw5EAoKSyJwpDf_6KYb-zZ-FxXjlDApdFTXBzUWjSvzbV81pt_lv-lEcLUHMeW_LVWUKwzwDec-bzA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3145214769</pqid></control><display><type>article</type><title>Pharmacy Closures and Anticonvulsant Medication Prescription Fills</title><source>American Medical Association Journals</source><creator>Anderson, Kelly E ; Sahu, Maitreyi ; DiStefano, Michael J ; Asche, Carl V ; Mattingly, T. Joseph</creator><creatorcontrib>Anderson, Kelly E ; Sahu, Maitreyi ; DiStefano, Michael J ; Asche, Carl V ; Mattingly, T. Joseph</creatorcontrib><description>While the number of US community pharmacies has remained somewhat constant, there is significant instability with 1 in 8 community pharmacies closing from 2009 to 2015.1 The effects of pharmacy closures on medication use are not well understood. Anticonvulsants are a protected class of Medicare drugs; plans must include them on formularies and have limitations on utilization management. Anticonvulsants are primarily indicated to treat epilepsy but are also used for neuropathic pain, migraine prophylaxis, and psychiatric disorders. Nonadherence has been linked to increased mortality and emergency department visits for epilepsy, and patients with untreated or undertreated neuropathic pain may experience worsening symptoms.2,3 This study examined the relationship between pharmacy closures and anticonvulsant prescription fills and number of days supplied in Colorado.</description><identifier>ISSN: 0098-7484</identifier><identifier>ISSN: 1538-3598</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.2024.19993</identifier><identifier>PMID: 39495537</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Anticonvulsants ; Emergency medical care ; Epilepsy ; Headache ; Mental disorders ; Migraine ; Neuralgia ; Pain ; Prophylaxis</subject><ispartof>JAMA : the journal of the American Medical Association, 2024-12, Vol.332 (21), p.1847-1849</ispartof><rights>Copyright American Medical Association Dec 3, 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jama/articlepdf/10.1001/jama.2024.19993$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.19993$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,314,780,784,3340,27924,27925,76489,76492</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39495537$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anderson, Kelly E</creatorcontrib><creatorcontrib>Sahu, Maitreyi</creatorcontrib><creatorcontrib>DiStefano, Michael J</creatorcontrib><creatorcontrib>Asche, Carl V</creatorcontrib><creatorcontrib>Mattingly, T. Joseph</creatorcontrib><title>Pharmacy Closures and Anticonvulsant Medication Prescription Fills</title><title>JAMA : the journal of the American Medical Association</title><addtitle>JAMA</addtitle><description>While the number of US community pharmacies has remained somewhat constant, there is significant instability with 1 in 8 community pharmacies closing from 2009 to 2015.1 The effects of pharmacy closures on medication use are not well understood. Anticonvulsants are a protected class of Medicare drugs; plans must include them on formularies and have limitations on utilization management. Anticonvulsants are primarily indicated to treat epilepsy but are also used for neuropathic pain, migraine prophylaxis, and psychiatric disorders. Nonadherence has been linked to increased mortality and emergency department visits for epilepsy, and patients with untreated or undertreated neuropathic pain may experience worsening symptoms.2,3 This study examined the relationship between pharmacy closures and anticonvulsant prescription fills and number of days supplied in Colorado.</description><subject>Anticonvulsants</subject><subject>Emergency medical care</subject><subject>Epilepsy</subject><subject>Headache</subject><subject>Mental disorders</subject><subject>Migraine</subject><subject>Neuralgia</subject><subject>Pain</subject><subject>Prophylaxis</subject><issn>0098-7484</issn><issn>1538-3598</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpd0E1LAzEQBuAgiq3Vs-BBFrx42TXJ5PNYi1WhYg96XrLZBLfsR93sCv33Bls9OJdhmIdheBG6JDgjGJO7jWlMRjFlGdFawxGaEg4qBa7VMZpirFUqmWITdBbCBsciIE_RBDTTnIOcovv1h-kbY3fJou7C2LuQmLZM5u1Q2a79Gutg2iF5cWVlzVB1bbKOxPbV9mdYVnUdztGJN3VwF4c-Q-_Lh7fFU7p6fXxezFepIUoNqWDW2ZIJ5goQpQHKlOdWcsuIZxYXWjjiJWCwWFBhlaeSUMsdKUrvvS1ghm73d7d99zm6MORNFayra9O6bgw5EAoKSyJwpDf_6KYb-zZ-FxXjlDApdFTXBzUWjSvzbV81pt_lv-lEcLUHMeW_LVWUKwzwDec-bzA</recordid><startdate>20241203</startdate><enddate>20241203</enddate><creator>Anderson, Kelly E</creator><creator>Sahu, Maitreyi</creator><creator>DiStefano, Michael J</creator><creator>Asche, Carl V</creator><creator>Mattingly, T. Joseph</creator><general>American Medical Association</general><scope>NPM</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20241203</creationdate><title>Pharmacy Closures and Anticonvulsant Medication Prescription Fills</title><author>Anderson, Kelly E ; Sahu, Maitreyi ; DiStefano, Michael J ; Asche, Carl V ; Mattingly, T. Joseph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a188t-64cecd464eb36da3248f5c75c41f4c0b96e1f7303c0626c8f2712c5e1bdfffcb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Anticonvulsants</topic><topic>Emergency medical care</topic><topic>Epilepsy</topic><topic>Headache</topic><topic>Mental disorders</topic><topic>Migraine</topic><topic>Neuralgia</topic><topic>Pain</topic><topic>Prophylaxis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anderson, Kelly E</creatorcontrib><creatorcontrib>Sahu, Maitreyi</creatorcontrib><creatorcontrib>DiStefano, Michael J</creatorcontrib><creatorcontrib>Asche, Carl V</creatorcontrib><creatorcontrib>Mattingly, T. Joseph</creatorcontrib><collection>PubMed</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anderson, Kelly E</au><au>Sahu, Maitreyi</au><au>DiStefano, Michael J</au><au>Asche, Carl V</au><au>Mattingly, T. Joseph</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacy Closures and Anticonvulsant Medication Prescription Fills</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><addtitle>JAMA</addtitle><date>2024-12-03</date><risdate>2024</risdate><volume>332</volume><issue>21</issue><spage>1847</spage><epage>1849</epage><pages>1847-1849</pages><issn>0098-7484</issn><issn>1538-3598</issn><eissn>1538-3598</eissn><abstract>While the number of US community pharmacies has remained somewhat constant, there is significant instability with 1 in 8 community pharmacies closing from 2009 to 2015.1 The effects of pharmacy closures on medication use are not well understood. Anticonvulsants are a protected class of Medicare drugs; plans must include them on formularies and have limitations on utilization management. Anticonvulsants are primarily indicated to treat epilepsy but are also used for neuropathic pain, migraine prophylaxis, and psychiatric disorders. Nonadherence has been linked to increased mortality and emergency department visits for epilepsy, and patients with untreated or undertreated neuropathic pain may experience worsening symptoms.2,3 This study examined the relationship between pharmacy closures and anticonvulsant prescription fills and number of days supplied in Colorado.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>39495537</pmid><doi>10.1001/jama.2024.19993</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0098-7484 |
ispartof | JAMA : the journal of the American Medical Association, 2024-12, Vol.332 (21), p.1847-1849 |
issn | 0098-7484 1538-3598 1538-3598 |
language | eng |
recordid | cdi_proquest_miscellaneous_3123807160 |
source | American Medical Association Journals |
subjects | Anticonvulsants Emergency medical care Epilepsy Headache Mental disorders Migraine Neuralgia Pain Prophylaxis |
title | Pharmacy Closures and Anticonvulsant Medication Prescription Fills |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T07%3A16%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacy%20Closures%20and%20Anticonvulsant%20Medication%20Prescription%20Fills&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Anderson,%20Kelly%20E&rft.date=2024-12-03&rft.volume=332&rft.issue=21&rft.spage=1847&rft.epage=1849&rft.pages=1847-1849&rft.issn=0098-7484&rft.eissn=1538-3598&rft_id=info:doi/10.1001/jama.2024.19993&rft_dat=%3Cproquest_pubme%3E3145214769%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3145214769&rft_id=info:pmid/39495537&rft_ama_id=2825803&rfr_iscdi=true |